FDA ex­tends re­search agree­ment with MIT-li­censed or­gan-on-chip sys­tems

The FDA on Wednes­day ex­tend­ed its four-year agree­ment with CN Bio, a de­vel­op­er of sin­gle- and mul­ti-or­gan-on-chip sys­tems used for drug dis­cov­ery, for an­oth­er three …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER